Sanofi-Aventis – Additional Information
Diabetic Investor has learned that in addition to the study that will be published in Diabetes, additional studies will be published in The Lancet. The studies to be published in the Lancet focus on Lantus and colon cancer. As we noted earlier Diabetic Investor has not seen any of these studies but we are aware of their existence.
According to well placed sources the concerns over Lantus and colon cancer are real. While Diabetic Investor could not pin down the incidence rate or whether this issue was confined to Lantus, our sources have indicated that the data is compelling.
Obviously we will remain on top of this developing story and will provide a complete analysis once all the data is in the public domain.